Skip to main content
School of Medicine
Precision Health Initiative
Traumatic Brain Injury
Graduate Medical Education
Health Professions Programs
Continuing Medical Education
Mental Health Services
Centers and Institutes
Northwest - Gary
Anatomy, Cell Biology and Physiology
Biochemistry Molecular Biology
Microbiology and Immunology
Pharmacology and Toxicology
Medical and Molecular Genetics
Obstetrics and Gynecology
Physical Medicine and Rehabilitation
Radiology and Imaging Sciences
Toggle Search Box
Bert H. O'Neil, MD
Bert H. O'Neil, MD
Adjunct Clinical Professor of Medicine
Indiana Cancer Pavilion, Suite 130 D
535 Barnhill Dr
RT 130 D
Indianapolis, IN 46202-5289
Titles & Appointments
Adjunct Clinical Professor of Medicine
Cusick Professor of Oncology
Director, Phase I &
GI Oncology Programs
University of California, Los Angeles
University of California, Irvine
Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A; Anticancer research 2017 Oct
Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T; Molecular bioSystems 2017 Nov 21
Excellent response to Anti-PD-1 therapy in a patient with hepatocellular carcinoma: case report and review of literature.
Mamdani H; Wu H; O'Neil BH; Sehdev A; Discovery medicine 2017 May
Immortal time bias or sorafenib effect in elderly patients with HCC?
Sanoff HK; Chang Y; Lund JL; O'Neil BH; Dusetzina SB; Hepatology (Baltimore, Md.) 2017 Jun 28
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB 3rd; Mulkerin DL; Mayer RJ; Blanke C; JAMA 2017 Jun 20
Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers.
Mosher CE; Secinti E; Johns SA; O'Neil BH; Helft PR; Shahda S; Jalal SI; Champion VL; Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2017 Jun 10
A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
Fogel EL; Shahda S; Sandrasegaran K; DeWitt J; Easler JJ; Agarwal DM; Eagleson M; Zyromski NJ; House MG; Ellsworth S; El Hajj I; O'Neil BH; Nakeeb A; Sherman S; The American journal of gastroenterology 2017 Jan 31
A Phase 1 Study to Assess the Relative Bioavailability of Two Capsule Formulations of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma.
Hanley MJ; Gupta N; Venkatakrishnan K; Bessudo A; Sharma S; O'Neil BH; Wang B; van de Velde H; Nemunaitis J; Journal of clinical pharmacology 2017 Aug 7
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Analysis.
Gupta N; Hanley MJ; Venkatakrishnan K; Bessudo A; Rasco DW; Sharma S; O'Neil BH; Wang B; Liu G; Ke A; Patel C; Rowland Yeo K; Xia C; Zhang X; Esseltine DL; Nemunaitis J; Journal of clinical pharmacology 2017 Aug 11
Clinical Pathways: Management of Quality and Cost in Oncology Networks in the Metastatic Colorectal Cancer Setting.
Ellis PG; O'Neil BH; Earle MF; McCutcheon S; Benson H; Krebs M; Lokay K; Barry A; Journal of oncology practice 2017 Apr 5
Locoregional and systemic therapy for hepatocellular carcinoma.
Gbolahan OB; Schacht MA; Beckley EW; LaRoche TP; O'Neil BH; Pyko M; Journal of gastrointestinal oncology 2017 Apr
Positive changes among patients with advanced colorectal cancer and their family caregivers: a qualitative analysis.
Mosher CE; Adams RN; Helft PR; O'Neil BH; Shahda S; Rattray NA; Champion VL; Psychology & health 2016 Oct 24
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan.
Cleary JM; McRee AJ; Shapiro GI; Tolaney SM; O'Neil BH; Kearns JD; Mathews S; Nering R; MacBeath G; Czibere A; Sharma S; Korn WM; Investigational new drugs 2016 Nov 16
Randomized phase II open-label study of mFOLFOX6 in combination with linifanib or bevacizumab for metastatic colorectal cancer.
O'Neil BH; Cainap C; Van Cutsem E; Gorbunova V; Karapetis CS; Berlin J; Goldberg RM; Qin Q; Qian J; Ricker JL; Fischer J; McKee MD; Carlson DM; Kim TW; Clinical colorectal cancer 2014 Jun 23
A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapy.
Patel JN; O'Neil BH; Deal AM; Ibrahim JG; Sherrill GB; Olajide OA; Atluri PM; Inzerillo JJ; Chay CH; McLeod HL; Walko CM; The oncologist 2014 Aug 12
Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital.
Keating K; Walko C; Stephenson B; O'Neil BH; Weiss J; Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2013 Nov 14
Looking for patient care?
To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.
Find a doctor